Incannex Healthcare Inc.

NORWEST NSW, C3 · Founded 2023 · CIK 0001873875 · Biotech · Public

Novel oral pharmaceutical treatments for obstructive sleep apnea

incannex.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$12M
1 Form D · Mar 2025
19 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$12,499,825
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2481CORNERSTONE PHARMACEUTICALS INC—$13M
2482DMC Limited——
2483Curie Co. Inc.—$13M
2484Incannex Healthcare Inc.—$12M
2485Genialis, Inc.—$12M
2486Borealis Biosciences——
2487PANOME BIO INC—$12M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • GEORGE ANASTASSOVDirector
  • LUIGI BARBATOExecutive Officer
  • LEKHRAM CHANGOERExecutive Officer
  • ROBERT CLARKDirector
  • JOEL LATHAMDirector · Executive Officer
  • JOSEPH SWANExecutive Officer
  • TROY VALENTINEDirector
  • PETER WIDDOWSDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.